We are live on ! Find out more
BMEZ icon

BlackRock Health Sciences Trust II

92 hedge funds and large institutions have $720M invested in BlackRock Health Sciences Trust II in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 46 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

1% more capital invested

Capital invested by funds: $716M → $720M (+$4.1M)

0% more funds holding

Funds holding: 9292 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.09% less ownership

Funds ownership: 43.75%42.66% (-1.1%)

54% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 46

Holders
92
Holders Change
Holders Change %
0%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
21
Reduced
46
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Saba Capital Management
New York
$327M +$1.94M +122,959 +0.6%
Morgan Stanley
2
Morgan Stanley
New York
$54.1M -$2.97M -188,617 -5%
RCM
3
Rivernorth Capital Management
Florida
$28.4M -$2.88M -182,682 -9%
SC
4
Sessa Capital
New York
$26.1M -$3.24M -205,432 -11%
SIA
5
Sit Investment Associates
Minnesota
$25.3M -$1.47M -93,467 -6%
Invesco
6
Invesco
Georgia
$24.3M +$203K +12,882 +0.8%
AC
7
Almitas Capital
California
$23.8M -$4.06M -257,550 -15%
KIM
8
Karpus Investment Management
New York
$23.1M -$1.12M -71,317 -5%
UBS Group
9
UBS Group
Switzerland
$22.4M -$912K -57,839 -4%
Bank of America
10
Bank of America
North Carolina
$19.4M -$1.92M -121,879 -9%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$17.4M -$1.08M -68,320 -6%
1CP
12
1607 Capital Partners
Virginia
$16.4M -$2.22M -140,642 -12%
PCM
13
Penserra Capital Management
California
$15.4M +$15.3M +971,616 New
Wells Fargo
14
Wells Fargo
California
$14.4M +$2.86M +181,624 +25%
Lazard Asset Management
15
Lazard Asset Management
New York
$11.2M -$1.5M -94,799 -12%
RJA
16
Raymond James & Associates
Florida
$8.06M +$1.94K +123 +0%
Stifel Financial
17
Stifel Financial
Missouri
$6.56M +$139K +8,843 +2%
Allspring Global Investments
18
Allspring Global Investments
North Carolina
$5.63M -$699K -44,337 -11%
AIA
19
Absolute Investment Advisers
Florida
$4.33M +$117K +7,399 +3%
RJFSA
20
Raymond James Financial Services Advisors
Florida
$4.28M +$1.21M +76,933 +40%
COLIM
21
City of London Investment Management
United Kingdom
$3.27M -$406K -25,753 -11%
LPL Financial
22
LPL Financial
California
$3.24M +$493K +31,240 +18%
OC
23
Oppenheimer & Co
New York
$3.24M +$18.2K +1,153 +0.6%
AGM
24
Alpine Global Management
New York
$3.13M +$990K +62,764 +46%
BBPWM
25
Blue Bell Private Wealth Management
Pennsylvania
$2.89M +$294K +18,668 +11%

BMEZ Hedge Fund Activity: Q3 2024 in Review

92 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q3 2024, worth a combined $720M — up 0.57% from $716M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BMEZ positions and 13 closed out — a net gain of 1 holder — while 21 added to existing stakes and 46 trimmed.

The largest buyer was Penserra Capital Management, opening a new position worth an estimated $15.3M. The largest seller was Almitas Capital, cutting an estimated $4.06M.

  • 92 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $720M of BlackRock Health Sciences Trust II stock for Q3 2024, up 0.57% quarter-over-quarter.
  • 14 funds opened new BlackRock Health Sciences Trust II positions in Q3 2024 and 13 closed out, a net change of +1 holder.
  • The largest BlackRock Health Sciences Trust II buyer in Q3 2024 was Penserra Capital Management, an estimated $15.3M added.
  • The largest BlackRock Health Sciences Trust II seller in Q3 2024 was Almitas Capital, an estimated $4.06M sold.

Based on aggregated 13F filings for Q3 2024.